Which Is More Damaging to the Conjunctiva- Timoptic or Xalatan?
March 11, 2009
Submit Comments
A recent article suggests that Xalatan stimulates less collagen production in the conjunctiva compared to Timoptic. I don’t do enough trabs to appreciate a difference. It’s too bad they used Xalatan as opposed to Lumigan or Travatan, as the latter two are prescribed much more than Xalatan, but I suppose it’s reasonable to assume the results woud be similar. Travatan Z, which is BAK-free, may be even more friendly to the conjunctiva, and I tend to prescribe it more than Lumigan if I suspect that the patient will ultimately end up getting a trab.
You might also enjoy...
- Which is Better to Lower IOP – Travatan vs. Lumigan vs. Xalatan
- Xalatan, Lumigan or Travatan for Glaucoma?
- Aton Pharma Launches Extended Program for Preservative-Free Timoptic® in Ocudose®
- New Entity- Prostaglandin-Associated Periorbitopathy
- Novogali Pharma Reports Positive Results in Phase II Study Comparing Treatment With Catioprost® vs. Travatan Z® in Glaucoma Patients
Comments
Jump down to form below to submit your own comments
